SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
BONIUK MILTON

(Last) (First) (Middle)
C/O NANOVIRICIDES, INC.
135 WOOD STREET, SUITE 205

(Street)
WEST HAVEN CT 06516

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
05/28/2013
3. Issuer Name and Ticker or Trading Symbol
NANOVIRICIDES, INC. [ NNVC ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.001 per share 200,000(1) D
Common Stock, par value $0.001 per share 666,667(2) I Held by Boniuk Charitable Foundation
Common Stock, par value $0.001 per share 666,667(3) I Held by Boniuk Investments Ltd
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants (4) 06/30/2014 Common Stock, par value $0.001 per share 100,000 $1 D
Unsecured 8% Coupon Series B Convertible Debenture (5) 01/31/2017 Common Stock, par value $0.001 per share (7) $1 I Held by Boniuk Charitable Foundation
Unsecured 8% Coupon Series B Convertible Debenture (6) 01/31/2017 Common Stock, par value $0.001 per share (7) $1 I Held by Boniuk Investments Ltd
Explanation of Responses:
1. Includes 200,000 shares of common stock held in the name of the Reporting Person and his wife, Laurie Boniuk.
2. Includes 666,667 shares of common stock held in the name of Boniuk Charitable Foundation, of which the Reporting Person holds voting and dispositive power.
3. Includes 666,667 shares of common stock held in the name of Boniuk Investments Ltd., of which the Reporting Person holds voting and dispositive power.
4. The warrants are presently exercisable and are held in the name of the Reporting Person and his wife, Laurie Boniuk.
5. The debenture is presently exercisable and is held in the name of Boniuk Charitable Foundation, of which the Reporting Person holds voting and dispositive power.
6. The debenture is presently exercisable and is held in the name of Boniuk Investments Ltd., of which the Reporting Person holds voting and dispositive power.
7. The debentures are convertible into shares of the Issuer's Common Stock, at a conversion price of $1.00 per share plus interest in shares of restricted Common Stock.
Remarks:
The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities.
/s/ Milton Boniuk 07/02/2013
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.